Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.
This study from the Tuberculosis Chemotherapy Centre, Madras, compares patients infected with isoniazid-resistant tubercle bacilli ("R" patients) with those infected with isoniazid-sensitive tubercle bacilli ("S" patients) as regards, first, their pretreatment status and, secondly, their response to a year's chemotherapy, either with isoniazid plus p-aminosalicylic acid (PAS) or with isoniazid alone. With regard to the first comparison, there was, on admission to treatment, little difference between the R and S patients in terms of the extent of the radiographic lesion, the extent of cavitation or the bacterial content of the sputum, but there were major differences in the age and sex distributions, the R patients showing a greater preponderance of young males than the S patients. As to the second comparison, statistically significant differences in the bacteriological response to treatment of the S and the R patients were observed in both the isoniazid-plus-PAS and the isoniazid-alone series, the response of the S patients being much better than that of the R patients. When the response to treatment was assessed in terms of radiographic progress and weight changes, however, hardly any difference was observed between the progress of the S and the R patients. The reasons for the response in the R patients are discussed.
S
S
DEVADATTA
A L
AL
BHATIA
R H
RH
ANDREWS
W
W
FOX
D A
DA
MITCHISON
S
S
RADHAKRISHNA
C V
CV
RAMAKRISHNAN
J B
JB
SELKON
S
S
VELU
D001407:Bacillus; D006801:Humans; D007194:India; D007538:Isoniazid; D013183:Sputum; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D007538:Isoniazid
TUBERCULOSIS, PULMONARY/therapy